Hengrui Pharma has lined up Bristol Myers Squibb as its latest partner in a deal worth up to $15.2 b...
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
Hengrui Pharma has lined up Bristol Myers Squibb as its latest partner in a deal worth up to $15.2 billion. The total value of the pact marks one of the...
Author: Endpoints News
Read Original Article